Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance*
暂无分享,去创建一个
H Nakajima | T. Suzuki | N. Kiyokawa | T. Taguchi | Toyo Suzuki | K. Mimori | H. Nakajima | Y. Katagiri | J. Fujimoto | T. Takeda | N Kiyokawa | Y U Katagiri | T Taguchi | T Suzuki | T Sekino | K Mimori | T Ebata | M Saito | H Nakao | T Takeda | J Fujimoto | H. Nakao | M. Saito | T. Sekino | T. Takeda | M. Saito | T. Ebata
[1] C. Lingwood,et al. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes , 1996, Glycoconjugate Journal.
[2] T. Suzuki,et al. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B. , 2001, Protein expression and purification.
[3] T. Suzuki,et al. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. , 2000, Experimental hematology.
[4] L. Johnston,et al. Distribution of ganglioside GM1 in L-alpha-dipalmitoylphosphatidylcholine/cholesterol monolayers: a model for lipid rafts. , 2000, Biophysical journal.
[5] K. Handa,et al. Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM. , 2000, Biochemical and biophysical research communications.
[6] C. Lingwood,et al. Apparent cooperativity in multivalent verotoxin-globotriaosyl ceramide binding: kinetic and saturation binding studies with [(125)I]verotoxin. , 2000, Biochimica et biophysica acta.
[7] K. Iwabuchi,et al. Reconstitution of Membranes Simulating “Glycosignaling Domain” and Their Susceptibility to Lyso-GM3* , 2000, The Journal of Biological Chemistry.
[8] M C Davies,et al. Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. , 2000, Analytical biochemistry.
[9] K. Willecke,et al. General or cell type-specific deletion and replacement of connexin-coding DNA in the mouse. , 2000, Methods.
[10] C. Lingwood,et al. Oxidation of aglycone of glycosphingolipids: serine and ceramide acid precursors for soluble glycoconjugates. , 2000, Methods in enzymology.
[11] C. Lingwood,et al. Analysis of interactions between glycosphingolipids and microbial toxins. , 2000, Methods in enzymology.
[12] Tetsuya Mori,et al. Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains* , 1999, The Journal of Biological Chemistry.
[13] K. Iwabuchi,et al. Glycosphingolipid-enriched Signaling Domain in Mouse Neuroblastoma Neuro2a Cells , 1999, The Journal of Biological Chemistry.
[14] C. Lingwood,et al. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis. , 1999, Biochemistry.
[15] S. McEwen,et al. Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.
[16] K. Iwabuchi,et al. Separation of “Glycosphingolipid Signaling Domain” from Caveolin-containing Membrane Fraction in Mouse Melanoma B16 Cells and Its Role in Cell Adhesion Coupled with Signaling* , 1998, The Journal of Biological Chemistry.
[17] H. Stockinger,et al. Polyunsaturated Fatty Acids Inhibit T Cell Signal Transduction by Modification of Detergent-insoluble Membrane Domains , 1998, The Journal of cell biology.
[18] K. Handa,et al. Signal Transduction Through Glyco(sphingo)lipids: Introduction and Recent Studies on Glyco(sphingo)lipid‐enriched Microdomains a , 1998, Annals of the New York Academy of Sciences.
[19] K. Iwabuchi,et al. GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells* , 1998, The Journal of Biological Chemistry.
[20] L. Montanaro,et al. The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin. , 1997, Toxicon : official journal of the International Society on Toxinology.
[21] A. Herrmann,et al. Interaction of Earthworm Hemolysin with Lipid Membranes Requires Sphingolipids* , 1997, The Journal of Biological Chemistry.
[22] C R MacKenzie,et al. Quantitative Analysis of Bacterial Toxin Affinity and Specificity for Glycolipid Receptors by Surface Plasmon Resonance* , 1997, The Journal of Biological Chemistry.
[23] R C Stevens,et al. Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. , 1996, Biochemistry.
[24] R. Norel,et al. Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. , 1996, Chemistry & biology.
[25] T. Obrig,et al. Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells. , 1995, The Journal of infectious diseases.
[26] C. Lingwood,et al. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin , 1995, Infection and immunity.
[27] C. Lingwood,et al. Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3). , 1995, International journal of biological macromolecules.
[28] C. Lingwood,et al. Capping and receptor‐mediated endocytosis of cell‐bound verotoxin (shiga‐like toxin) 1: Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization , 1994, Journal of cellular physiology.
[29] T. Sixma,et al. Galactose‐binding site in Escherichia coli heat‐labile enterotoxin (LT) and cholera toxin (CT) , 1994, Molecular microbiology.
[30] J. Martial,et al. Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.
[31] M. James,et al. Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution , 1994, Nature Structural Biology.
[32] C. Lingwood,et al. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro , 1993, Infection and immunity.
[33] J. Samuel,et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice , 1993, Infection and immunity.
[34] Kristian Prydz,et al. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum , 1992, Nature.
[35] M. Masserini,et al. Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin. , 1992, Biochemistry.
[36] C. Lingwood,et al. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. , 1991, The Journal of biological chemistry.
[37] H R Smith,et al. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. , 1990, Archives of disease in childhood.
[38] B Rowe,et al. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. , 1990, Archives of disease in childhood.
[39] S. Ostroff,et al. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. , 1989, The Journal of infectious diseases.
[40] J. Brown,et al. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1 , 1989, The Journal of cell biology.
[41] S. Saxena,et al. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. , 1989, The Journal of biological chemistry.
[42] T. Yutsudo,et al. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. , 1988, Microbial pathogenesis.
[43] T. Yutsudo,et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. , 1988, European journal of biochemistry.
[44] B. Rowe,et al. Properties of strains of Escherichia coli belonging to serogroup O 157 with special reference to production of Vero cytotoxins VTl and VT2 , 1987, Epidemiology and Infection.
[45] C. Lingwood,et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. , 1987, The Journal of biological chemistry.
[46] M. P. Jackson,et al. Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli. , 1987, Microbial pathogenesis.
[47] G. Keusch,et al. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin- binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide , 1986, The Journal of experimental medicine.
[48] A A Spector,et al. Membrane lipid composition and cellular function. , 1985, Journal of lipid research.
[49] P. Brûlet,et al. Structural and dynamical aspects of membrane immunochemistry using model membranes. , 1977, Biochemistry.